| Naslov: | The efficacy of probiotics as antiviral agents for the treatment of rotavirus gastrointestinal infections in children : an updated overview of literature |
|---|
| Avtorji: | ID Steyer, Andrej (Avtor)
ID Mičetić-Turk, Dušanka (Avtor)
ID Fijan, Sabina (Avtor) |
|---|
| Datoteke: |  Steyer-2022-The_Efficacy_of_Probiotics_as_Anti.pdf (394,77 KB)
MD5: 1B7A80CC6831F412178D5908245F520B
 https://doi.org/10.3390/microorganisms10122392
|
|---|
| Jezik: | Angleški jezik |
|---|
| Vrsta gradiva: | Znanstveno delo |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: | MF - Medicinska fakulteta
|
|---|
| Opis: | Enteric viruses, including the rotavirus, norovirus, and adenoviruses, are the most common cause of acute gastroenteritis. The rotavirus disease is especially prevalent among children, and studies over the past decade have revealed complex interactions between rotaviruses and the gut microbiota. One way to treat and prevent dysbiosis is the use of probiotics as an antiviral agent. This review focuses on the latest scientific evidence on the antiviral properties of probiotics against rotavirus gastroenteric infections in children. A total of 19 studies exhibited a statistically significant antiviral effect of probiotics. The main probiotics that were effective were Saccharomyces cerevisiae var. boulardii, Lacticaseibacillus rhamnosus GG, and various multi-strain probiotics. The underlying mechanism of the probiotics against rotavirus gastroenteric infections in children included immune enhancement and modulation of intestinal microbiota leading to shortening of diarrhoea. However, several clinical studies also found no significant difference in the probiotic group compared to the placebo group even though well-known strains were used, thus showing the importance of correct dosage, duration of treatment, quality of probiotics and the possible influence of other factors, such as the production process of probiotics and the influence of immunisation on the effect of probiotics. Therefore, more robust, well-designed clinical studies addressing all factors are warranted. |
|---|
| Ključne besede: | probiotics, microbiota, rotaviruses |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 27.10.2022 |
|---|
| Datum sprejetja članka: | 29.11.2022 |
|---|
| Datum objave: | 02.12.2022 |
|---|
| Založnik: | MDPI |
|---|
| Leto izida: | 2022 |
|---|
| Št. strani: | Str. 1-21 |
|---|
| Številčenje: | Letn. 10, Št. 12, št. člnka 2392 |
|---|
| PID: | 20.500.12556/DKUM-89370  |
|---|
| UDK: | 613.292:616.3 |
|---|
| COBISS.SI-ID: | 135120643 |
|---|
| DOI: | 10.3390/microorganisms10122392 |
|---|
| ISSN pri članku: | 2076-2607 |
|---|
| Datum objave v DKUM: | 05.07.2024 |
|---|
| Število ogledov: | 95 |
|---|
| Število prenosov: | 11 |
|---|
| Metapodatki: |    |
|---|
| Področja: | Ostalo
|
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Skupna ocena: | (0 glasov) |
|---|
| Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
|---|
| Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
